Skip to main content
Home
language-selector-globe Slovenia | en
Choose Location
language-selector-globe Slovenia |
EnglishSlovenian
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Latin America | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Israel | he
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Slovenia | sl
Slovenia | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Novartis | en
Sandoz | en
Egypt | en
South Africa | en
Turkey | tr
language-selector-globe si
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latin America | es
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
Slovenia | sl
Slovenia | en
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Slovenia 
      • Country Leadership Team 
      • Strategy 
      • Diversity, Equity and Inclusion 
      • People and culture 
      • Products 
      • Contacts 
      Novartis in Slovenia. Scientist in laboratory About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Products 
      Older patient and younger caregiver Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Pipeline 
      • Adverse Event Reporting 
      • Clinical studies 
      Elderly gentleman at a doctor's appointment Healthcare Professionals
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Reporting 
      Two people holding hands ESG
    • Media 
      • News Archive 
      • Media Contact 
      Man reading newspaper Media
    • Careers 
      • Careers at Novartis in Slovenia 
      • How We Work 
      • Wellbeing 
      • Diversity, Equity and Inclusion 
      • BioCamp 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Awards and Recognition 
      Man and woman behind computer Careers
    • Development and production of innovative medicines 
    • BioCamp 2024 
    Scientist, Novartis in Slovenia Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Allergy-Territory Account Specialist – Green Bay, WI – Remote Field Sales (USA) USA US Innovative Medicines Sales 27 August 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development 25 April 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access 17 October 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access 17 October 2024
Patient Support - Manager, Program Operations Management East Hanover USA US Innovative Medicines Marketing 17 October 2024
Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote Field Non-Sales (USA) USA US Innovative Medicines Sales 17 October 2024
Associate Director, Integrated Insights, New Products, Oncology East Hanover USA US Innovative Medicines Marketing 17 October 2024
Intake Specialist INSURGENTES Mexico US Innovative Medicines Facilities & Administration 02 September 2024
Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development 17 October 2024
Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote Field Non-Sales (USA) USA US Innovative Medicines Sales 17 October 2024
Associate Director Commercial Analytics (Cardiovascular) Distant Employee - Distant Working Arrangement (DWA) (USA) USA US Innovative Medicines Marketing 18 October 2024
ED, Product Strategy Lead - Renal East Hanover USA US Innovative Medicines Marketing 18 October 2024
US Market Access Future Leaders Program East Hanover USA US Innovative Medicines Market Access 18 October 2024
Director Data Science East Hanover USA US Innovative Medicines Data and Digital 21 October 2024
Allergy Territory Account Specialist- Fort Worth- Remote Field Sales (USA) USA US Innovative Medicines Sales 22 October 2024
Neuroscience Territory Account Specialist – Boston– Remote Field Sales (USA) USA US Innovative Medicines Sales 22 October 2024
Allergy Territory Account Specialist- Austin West- Remote Field Sales (USA) USA US Innovative Medicines Sales 22 October 2024
Allergy Territory Account Specialist- Austin East- Remote Field Sales (USA) USA US Innovative Medicines Sales 22 October 2024
Rheumatology Territory Account Specialist - Fort Wayne - Remote Field Sales (USA) USA US Innovative Medicines Sales 22 October 2024
Renal / Rare Disease Territory Account Specialist – Long Beach, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales 23 October 2024
Allergy- Territory Account Specialist- Corpus Christi- Remote Field Sales (USA) USA US Innovative Medicines Sales 23 October 2024
Neuroscience Territory Account Specialist – Boise, ID – Remote Field Sales (USA) USA US Innovative Medicines Sales 23 October 2024
Associate Medical Director-RLT Remote Position (USA) USA US Innovative Medicines Research & Development 24 October 2024
Neurology Territory Account Specialist – Nashville / Knoxville – Remote Field Sales (USA) USA US Innovative Medicines Sales 24 October 2024
Neuroscience Territory Account Specialist – Springfield, Peoria, Champagne/Urbana – Remote Field Sales (USA) USA US Innovative Medicines Sales 25 October 2024
Neuro Territory Account Specialist – New Orleans – Remote Field Sales (USA) USA US Innovative Medicines Sales 25 October 2024
Director, NPS Analytics - CRM East Hanover USA US Innovative Medicines Marketing 25 October 2024
Director, Product Strategy Lead, Urology/Prostate East Hanover USA US Innovative Medicines Marketing 25 October 2024
AD, Case Manager Immunology East Hanover USA US Innovative Medicines Sales 25 October 2024
Neuro Territory Account Specialist – San Diego – Remote Field Sales (USA) USA US Innovative Medicines Sales 26 October 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42

Novartis Slovenia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Media
  • Career
Media
  • News Archive
Our Portfolio
  • Novartis Products
  • Novartis Pipeline
Other Novartis websites
  • Global site
Footer Bottom
© 2024 Novartis d.o.o.
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience